NCT03059537View on ClinicalTrials.gov

Validation of Stimulated ∆FGF19 for Diagnosing Bile Acid Diarrhoea

PHASE4CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

March 13, 2017

Primary Completion Date

November 27, 2017

Study Completion Date

November 27, 2017

Conditions
Bile Acid Malabsorption
Interventions
DRUG

Oral chenodeoxycholic acid stimulation

oral intake of chenodeoxycholic acid to stimulate the ileal bile acid transporter and farnesoid X receptor

Trial Locations (5)

2650

Hvidovre University Hospital, Hvidovre

4300

Zealand University Hopsital, Holbæk

4600

Zealand University Hospital, Køge

8000

Aarhus University Hospital, Aarhus

9000

Aalborg University Hospital, Aalborg

All Listed Sponsors
lead

Lars Kristian Munck

OTHER

NCT03059537 - Validation of Stimulated ∆FGF19 for Diagnosing Bile Acid Diarrhoea | Biotech Hunter | Biotech Hunter